发明申请
US20100015181A1 Vaccine formulation 失效
疫苗配方

Vaccine formulation
摘要:
Spore coat-associated proteins from members of Bacillus genera, and in particular spore-coat associated protein N (CotN), have utilisation as adjuvants in vaccine formulations. The vaccine formulations most likely contain a virulence factor of bacterial origin, which in the case of Bacillus genera is the protective antigen.
公开/授权文献
信息查询
0/0